MIH
RDHL

Meitav Investment House’s Redhill Biopharma RDHL Stock Holding History

Meitav Investment House’s Portfolio RDHL Stock Details RDHL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-13
Closed -$57K – 431
2020
Q1 		$57K Buy
+13
New +$65K ﹤0.01% 364
2019
Q4 		– Sell
-15
Closed -$107K – 469
2019
Q3 		$107K Hold
15
– – 0.01% 433
2019
Q2 		$94K Hold
15
– – 0.01% 419
2019
Q1 		$123K Sell
15
-35
-70% -$277K 0.01% 371
2018
Q4 		$278K Buy
50
+1
+2% +$7.66K 0.02% 271
2018
Q3 		$422K Buy
49
+1
+2% +$8.15K 0.02% 345
2018
Q2 		$388K Hold
48
– – 0.02% 348
2018
Q1 		$247K Hold
48
– – 0.01% 302
2017
Q4 		$244K Buy
+48
New +$323K 0.01% 184

Other funds holding RDHL

DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
II
Ibex Investors Denver, Colorado $152M AUM 19.17% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
SFS
Sowell Financial Services North Little Rock, Arkansas $3.06B AUM 30.02% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Meitav Investment House's RDHL Position: Q2 2020 in Review

Meitav Investment House sold out of Redhill Biopharma (RDHL) in Q2 2020, closing a stake of 13 shares — an estimated $57K sold.

Meitav Investment House first reported a position in RDHL in Q4 2017 and held it in 9 quarters. The position peaked at $422K in Q3 2018. 41 funds tracked by Wall St. Rank hold RDHL as of Q2 2020.

  • Meitav Investment House reported no remaining Redhill Biopharma position as of Q2 2020 after selling out during the quarter.
  • Meitav Investment House sold 13 Redhill Biopharma shares in Q2 2020, an estimated $57K.
  • Meitav Investment House first reported a position in Redhill Biopharma in Q4 2017 and held it in 9 quarters.
  • Meitav Investment House's Redhill Biopharma position peaked at $422K in Q3 2018.
  • 41 funds tracked by Wall St. Rank held Redhill Biopharma as of Q2 2020.

Based on Meitav Investment House's 13F filing for Q2 2020, filed 10 Aug 2020.